Prevalence of the use of prescription stimulants as "study drugs" by UK university students: A brief report
Ffinian Jones,Philip M. Newton
DOI: https://doi.org/10.1002/brb3.3419
IF: 3.1
2024-02-14
Brain and Behavior
Abstract:We investigated the number of students in the United Kingdom using certain stimulant medicines, without a prescription, as "study drugs" to improve their performance in assessments. There is concern that these drugs can have harmful side effects and may be considered cheating. We found that a small minority of students are using these drugs, although one (modafinil) is more common. Most importantly, we found that there needs to be rigorous high‐quality research to truly understand how many students are using these medicines and the possible harmful effects. Introduction There is media concern over students using prescription stimulants as "cognitive enhancers" to try and improve their academic performance. However, there is limited evidence about the prevalence of this behaviour in the United Kingdom, or whether it has increased in recent years. Methods We review survey studies on students' use of cognitive enhancers. Results Overall reported use is low, with some inconclusive evidence that it is increasing. Use of modafinil appears to be higher than that of methylphenidate or dexamphetamine. Conclusion There is a clear need for large‐scale research in this area, using representative sampling and survey methods that protect student anonymity.
behavioral sciences,neurosciences
What problem does this paper attempt to address?